Clinical Trial Update: Safety and Efficacy of 5% Monolaurin Vaginal Gel Administered Intravaginally for the Treatment of Bacterial Vaginosis [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety and efficacy of 5% monolaurin vaginal gel for treatment of bacterial vaginosis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Vaginosis

Drugs mentioned

• monolaurin vaginal gel (monolaurin)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Bacterial Vaginosis | Phase 2 | Status: COMPLETED | Results posted: 2018-12-28